AtriCure Price to Free Cash Flow Ratio 2010-2025 | ATRC
Historical price to free cash flow ratio values for AtriCure (ATRC) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| AtriCure Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-05-20 | 34.05 | 137.91 | |
| 2025-03-31 | 32.26 | $0.25 | 130.66 |
| 2024-12-31 | 30.56 | $0.02 | 1863.41 |
| 2024-09-30 | 28.04 | $-0.02 | 0.00 |
| 2024-06-30 | 22.77 | $-0.42 | 0.00 |
| 2024-03-31 | 30.42 | $-0.53 | 0.00 |
| 2023-12-31 | 35.69 | $-0.16 | 0.00 |
| 2023-09-30 | 43.80 | $-0.28 | 0.00 |
| 2023-06-30 | 49.36 | $-0.38 | 0.00 |
| 2023-03-31 | 41.45 | $-0.38 | 0.00 |
| 2022-12-31 | 44.38 | $-0.85 | 0.00 |
| 2022-09-30 | 39.10 | $-0.81 | 0.00 |
| 2022-06-30 | 40.86 | $-0.69 | 0.00 |
| 2022-03-31 | 65.67 | $-0.89 | 0.00 |
| 2021-12-31 | 69.53 | $-0.51 | 0.00 |
| 2021-09-30 | 69.55 | $-0.42 | 0.00 |
| 2021-06-30 | 79.33 | $-0.29 | 0.00 |
| 2021-03-31 | 65.52 | $-0.37 | 0.00 |
| 2020-12-31 | 55.67 | $-0.60 | 0.00 |
| 2020-09-30 | 39.90 | $-0.85 | 0.00 |
| 2020-06-30 | 44.95 | $-1.10 | 0.00 |
| 2020-03-31 | 33.59 | $-0.80 | 0.00 |
| 2019-12-31 | 32.51 | $-0.74 | 0.00 |
| 2019-09-30 | 24.94 | $-0.53 | 0.00 |
| 2019-06-30 | 29.84 | $-0.27 | 0.00 |
| 2019-03-31 | 26.79 | $-0.36 | 0.00 |
| 2018-12-31 | 30.60 | $-0.30 | 0.00 |
| 2018-09-30 | 35.03 | $-0.30 | 0.00 |
| 2018-06-30 | 27.05 | $-0.45 | 0.00 |
| 2018-03-31 | 20.52 | $-0.47 | 0.00 |
| 2017-12-31 | 18.24 | $-0.47 | 0.00 |
| 2017-09-30 | 22.37 | $-0.51 | 0.00 |
| 2017-06-30 | 24.25 | $-0.48 | 0.00 |
| 2017-03-31 | 19.15 | $-0.64 | 0.00 |
| 2016-12-31 | 19.57 | $-0.72 | 0.00 |
| 2016-09-30 | 15.82 | $-1.06 | 0.00 |
| 2016-06-30 | 14.13 | $-1.25 | 0.00 |
| 2016-03-31 | 16.83 | $-1.12 | 0.00 |
| 2015-12-31 | 22.44 | $-1.13 | 0.00 |
| 2015-09-30 | 21.91 | $-1.05 | 0.00 |
| 2015-06-30 | 24.64 | $-0.95 | 0.00 |
| 2015-03-31 | 20.49 | $-0.99 | 0.00 |
| 2014-12-31 | 19.96 | $-1.17 | 0.00 |
| 2014-09-30 | 14.72 | $-1.09 | 0.00 |
| 2014-06-30 | 18.38 | $-0.98 | 0.00 |
| 2014-03-31 | 18.81 | $-0.86 | 0.00 |
| 2013-12-31 | 18.68 | $-0.39 | 0.00 |
| 2013-09-30 | 10.98 | $-0.25 | 0.00 |
| 2013-06-30 | 9.50 | $-0.33 | 0.00 |
| 2013-03-31 | 7.92 | $-0.35 | 0.00 |
| 2012-12-31 | 6.90 | $-0.30 | 0.00 |
| 2012-09-30 | 7.44 | $-0.36 | 0.00 |
| 2012-06-30 | 9.61 | $-0.31 | 0.00 |
| 2012-03-31 | 9.95 | $-0.25 | 0.00 |
| 2011-12-31 | 11.10 | $-0.22 | 0.00 |
| 2011-09-30 | 9.74 | $-0.03 | 0.00 |
| 2011-06-30 | 12.90 | $0.00 | 0.00 |
| 2011-03-31 | 11.38 | $0.02 | 539.34 |
| 2010-12-31 | 10.27 | $-0.12 | 0.00 |
| 2010-09-30 | 7.87 | $-0.22 | 0.00 |
| 2010-06-30 | 6.65 | $-0.12 | 0.00 |
| 2010-03-31 | 5.89 | $-0.09 | 0.00 |
| 2009-12-31 | 6.04 | $-0.06 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.604B | $0.465B |
| AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $235.835B | 28.36 |
| Boston Scientific (BSX) | United States | $157.798B | 39.50 |
| Stryker (SYK) | United States | $150.649B | 31.50 |
| EssilorLuxottica (ESLOY) | France | $134.205B | 0.00 |
| Medtronic (MDT) | Ireland | $111.543B | 16.29 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.908B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.033B | 27.90 |
| ResMed (RMD) | United States | $37.148B | 27.90 |
| GE HealthCare Technologies (GEHC) | United States | $33.471B | 15.89 |
| Agilent Technologies (A) | United States | $32.342B | 21.36 |
| Terumo (TRUMY) | Japan | $27.583B | 35.83 |
| Insulet (PODD) | United States | $22.931B | 90.01 |
| Koninklijke Philips (PHG) | Netherlands | $22.436B | 16.13 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.948B | 12.17 |
| Baxter (BAX) | United States | $16.150B | 12.06 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.745B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.231B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.767B | 23.55 |
| Lantheus Holdings (LNTH) | United States | $5.414B | 13.66 |
| Prestige Consumer Healthcare (PBH) | United States | $4.395B | 19.63 |
| Perrigo (PRGO) | Ireland | $3.739B | 9.48 |
| Haemonetics (HAE) | United States | $3.484B | 15.18 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.396B | 25.05 |
| Envista Holdings (NVST) | United States | $3.000B | 24.93 |
| QuidelOrtho (QDEL) | United States | $2.203B | 15.15 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| LeMaitre Vascular (LMAT) | United States | $1.942B | 43.41 |
| Neogen (NEOG) | United States | $1.389B | 17.78 |
| Kestra Medical Technologies (KMTS) | United States | $1.245B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.213B | 12.31 |
| Green Thumb Industries (GTBIF) | United States | $1.175B | 26.43 |
| BioLife Solutions (BLFS) | United States | $1.090B | 0.00 |
| InMode (INMD) | Israel | $1.011B | 9.25 |
| Phibro Animal Health (PAHC) | United States | $0.978B | 12.50 |
| CeriBell (CBLL) | United States | $0.644B | 0.00 |
| Evolus (EOLS) | United States | $0.638B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.566B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.553B | 0.00 |
| Owens & Minor (OMI) | United States | $0.548B | 4.54 |
| Valneva SE (VALN) | France | $0.530B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.474B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.456B | 0.00 |
| Surmodics (SRDX) | United States | $0.422B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.349B | 0.00 |
| SNDL (SNDL) | Canada | $0.342B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.330B | 12.14 |
| Canopy Growth (CGC) | Canada | $0.302B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.300B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.282B | 50.20 |
| Sanara MedTech (SMTI) | United States | $0.277B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 22.50 |
| Sanuwave Health (SNWV) | United States | $0.253B | 0.00 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.250B | 0.00 |
| ZimVie (ZIMV) | United States | $0.244B | 11.08 |
| Biote (BTMD) | United States | $0.222B | 6.25 |
| Brainsway (BWAY) | Israel | $0.201B | 53.25 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| Omeros (OMER) | United States | $0.195B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Quanterix (QTRX) | United States | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.177B | 14.41 |
| Organigram Global (OGI) | Canada | $0.175B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.167B | 0.00 |
| Exagen (XGN) | United States | $0.135B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.130B | 15.94 |
| Jin Medical (ZJYL) | China | $0.126B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| Agape ATP (ATPC) | $0.102B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Fonar (FONR) | United States | $0.084B | 10.81 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.060B | 0.00 |
| United Health Products (UEEC) | United States | $0.058B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| ImmuCell (ICCC) | United States | $0.050B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.040B | 13.69 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 30.71 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Acuren (TIC) | United States | $0.000B | 0.00 |